Annie Wong 黃毅敏
@anmwongNZ
Followers
1K
Following
18K
Statuses
3K
🇳🇿Medical Oncologist👩🏻⚕️Senior lecturer University Otago Wellington/Auckland 👩🏻🏫 Mother🤱🏻 Food enthusiast👩🏻🍳#MedEd
Wellington City, New Zealand
Joined December 2013
Inspired by Chinese Ao/NZ writers @plainricedinner @juliezhuu I wrote a personal essay, Yuan Fen 緣份, about being an immigrant oncologist and my Chinese patients As immigrants, we see each other’s hopes & struggles, so I’m always thrilled i can contribute in my small way
17
11
100
RT @herbloong: Join us for the #inaugural @myESMO #ESMOTATAsia25 meeting in July in my home 🏡 #hongkong 🇭🇰! We look forward to showcasing a…
0
1
0
RT @jaygirimd: @NIH 12/ We may expect a higher proportion of high overhead clinical research to be industry sponsored. Industry already pla…
0
7
0
@DrMLChua @xrtGenomics This opens up an important conversation. Universities in Australia/NZ charging 35-45%. It’s a huge consideration, not putting salary into grants. Paying only consumables but then no one to do the work!
1
0
1
RT @PBlanchardMD: Prof Brigette Ma discussing the new TNM staging system for nasopharyngeal cancer at ESMO Asia.
0
18
0
RT @myESMO: 📣 Abstract submission for the brand new #ESMOTATAsia25 Congress is open! Join us to chart new paths in anticancer #drugdevelopm…
0
5
0
RT @sharonnahm: Encouraging all MOGA members to register for this interesting webinar on 'Conflicts of Interest in Medical Oncology'. (Als…
0
2
0
RT @DrJNaidoo: Important paper on CNS activity of Ipi-Nivo for Melanoma Brain Metastases after prior antiPD1 @JAMAOnc: - 28pts - CNS ORR 1…
0
20
0
RT @myESMO: ESMO launches its globalised Patient Advocates Working Group aiming at amplifying the voices of patients worldwide 🔗 Read mor…
0
5
0
@Mal_Itchins @TOGAANZ @DrMelMoore @MichaelBoyer1 🤩 is it too cheeky to ask @peters_solange to record a podcast 🎤 as part of her keynote for the @TOGAANZ ASM? Absolute inspiration in so many ways
1
0
3
RT @RyanNipp: Management of immune checkpoint inhibitor-associated toxicities in older adults with cancer: recommendations from the Interna…
0
36
0
RT @StephenVLiu: Dr. @JordiRemon discusses uncommon #EGFR mutations in NSCLC at #ITCD2025. Afatinib approved here but osimertinib has some…
0
28
0
Just finished a superstar clinic where all patients at least 3 years cancer-free after treatment for their metastatic disease! Some getting discharged after 5 years 🤩🤩🤩🧧🧧🧧🥳🥳🥳 Great way to start the new year! #HappyLunarNewYear2025
1
0
19
RT @CureMelanoma: On December 27th, 2024 the @US_FDA approved Opdivo Qvantig, a new and convenient option for treating various adult solid…
0
3
0
RT @CathyEngMD: We were just notified all @NIH @NCICTEP_ClinRes @NCI meetings are now CANCELLED. Investigators PLS continue your hard wor…
0
103
0
RT @DrJNaidoo: Great talk by @RamalingamMD on targeted therapy for early stage NSCLC. Key questions: - post LAURA trial, can we avoid chem…
0
4
0
9.5% MET and 7.9% EGFR detected in pts w lung Squamous cell carcinoma with no smoking history. We are finding more of this with reflex testing in early stage disease too #lcsm
Biomarker testing can help identify actionable mutations in patients with SqNSCLC, especially in those without a history of smoking. Testing is not performed consistently in this setting. #LCSM
0
4
14
RT @jsoriamd: Reported associations between tumor-infiltrating lymphocyte subsets, including cytotoxic CD8+ T cells, CD4+ T helper cells, T…
0
23
0